Battelle Wins $102M NIAID Biodefense Research Contract
R&D Leader Secures Federal Contract for Evaluation and Testing Services for Vaccines and Other Biologics for Infectious Disease
(firmenpresse) - COLUMBUS, OH -- (Marketwire) -- 07/18/12 -- has won a single-source award from the U.S. Department of Health and Human Services' National Institutes of Health for evaluation and testing services for vaccines and other biologics for infectious diseases. The work, worth as much as $102.5 million for 10 years, will be conducted at Battelle's biosafety level 3 laboratories and new toxicology research facility in West Jefferson, Ohio.
The award will support the National Institute of Allergy and Infectious Diseases (NIAID) Division of Microbiology and Infectious Diseases (DMID) in development of medical countermeasures against infectious diseases, including vaccines and biologics directed against emerging and biodefense pathogens.
"This contract is exactly the type of work we are built for at Battelle," said Barbara Kunz, President of Battelle's Health and Life Sciences Global Business. "It spans several areas of expertise and supports the government clients that we hold in high regard."
The effort provides for a diverse suite of preclinical, nonclinical and clinical testing on an as-needed basis to obtain critical data that will contribute to an eventual decision by the Food and Drug Administration about the product's safety and efficacy.
The contract will evaluate the efficacy, immunogenicity, and safety of vaccines and analyze samples from clinical trials. These services are intended to help a wide variety of investigators obtain critical data needed to acquire additional funding, gain prospective partnerships, fulfill regulatory requirements, and complete studies needed to apply for an IND and enter Phase I/II/III clinical trials.
As the world's largest independent research and development organization, Battelle provides innovative solutions to the world's most pressing needs through its four global businesses: Laboratory Management; National Security; Health and Life Sciences; and Energy, Environment and Material Sciences. It advances scientific discovery and application by conducting $6.5 billion in global R&D annually through contract research, laboratory management and technology commercialization. Headquartered in Columbus, Ohio, Battelle oversees 22,000 employees in more than 130 locations worldwide, including seven national laboratories which Battelle manages or co-manages for the U.S. Department of Energy and the U.S. Department of Homeland Security and a nuclear energy lab in the United Kingdom.
Battelle also is one of the nation's leading charitable trusts focusing on societal and economic impact and actively supporting and promoting science, technology, engineering and mathematics (STEM) education.
Image Available:
For more information contact
Katy Delaney
(614) 424-7208
T.R. Massey
(614) 424-5544
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 18.07.2012 - 08:30 Uhr
Sprache: Deutsch
News-ID 1134276
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
COLUMBUS, OH
Phone:
Kategorie:
National
Anmerkungen:
Diese Pressemitteilung wurde bisher 161 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Battelle Wins $102M NIAID Biodefense Research Contract
"
steht unter der journalistisch-redaktionellen Verantwortung von
Battelle (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
